Published by Josh White on 16th October 2024
(Sharecast News) - GSK announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for gepotidacin, a first-in-class oral antibiotic, under priority review.
URL: http://www.digitallook.com/dl/news/story/34626766/...